Analgesics - Bhutan

  • Bhutan
  • In 2024, the revenue in the Analgesics market in Bhutan amounts to US$0.50m.
  • This market is expected to experience an annual growth rate of 8.45% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, reaching US$7,243.00m in 2024.
  • Considering the total population figures, in Bhutan generates per person revenues of US$0.64 in 2024.
  • Bhutan's growing interest in alternative medicine has led to a surge in demand for traditional herbal analgesics in the OTC Pharmaceuticals market.

Key regions: Brazil, Europe, Germany, Canada, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Bhutan is experiencing steady growth due to changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in Bhutan are shifting towards self-medication and the use of over-the-counter analgesics. This trend is driven by the increasing awareness of the population about common ailments and the availability of a wide range of analgesic products in the market. Customers in Bhutan prefer convenience and affordability when it comes to purchasing analgesics, leading to a growing demand for easily accessible and reasonably priced products.Trends in the market show a shift towards natural and herbal analgesics in Bhutan. This can be attributed to the cultural and traditional beliefs of the Bhutanese people, who have a long history of using natural remedies for pain relief. The demand for natural analgesics is also driven by the global trend towards natural and organic products, as well as the growing concern for the potential side effects of synthetic analgesics. Manufacturers in Bhutan are capitalizing on this trend by introducing a variety of natural and herbal analgesic products to cater to the changing preferences of the customers.Local special circumstances in Bhutan, such as the limited access to healthcare facilities in remote areas, also contribute to the growth of the Analgesics market. In these areas, where access to doctors and pharmacies is limited, self-medication becomes the primary option for pain relief. As a result, the demand for analgesics is higher in these areas compared to urban areas where healthcare facilities are more accessible. Manufacturers and distributors in Bhutan are expanding their reach to these remote areas to meet the growing demand for analgesics.Underlying macroeconomic factors, such as the growing population and increasing disposable income, play a significant role in the development of the Analgesics market in Bhutan. With a larger population, the demand for healthcare products, including analgesics, naturally increases. The rising disposable income allows individuals to spend more on healthcare products, further driving the growth of the market. Additionally, the government's focus on improving healthcare infrastructure and providing better healthcare services to the population also contributes to the growth of the market.In conclusion, the Analgesics market in Bhutan is growing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the demand for natural and herbal analgesics, limited access to healthcare facilities in remote areas, and the growing population and disposable income are all driving the growth of the market. Manufacturers and distributors in Bhutan are adapting to these trends and special circumstances to meet the evolving needs of the customers and capitalize on the opportunities in the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)